Table 5.
Host – pathogen interactions revealed from the text mining of the literature.
S. No | Host Pathogen Interactions | Interactions Causes | Reference | |
---|---|---|---|---|
Pathogen Proteins | Human Proteins | |||
1 | CagA | E-cadherin | Gastric cancer | Murata-Kamiya et al. [48] |
Erk mitogen-activated protein kinase | Gastric cancer | Zhu et al. [47] | ||
Transforming growth factor-b-activated kinase 1 (TAK1) | Gastric cancer | Lamb et al. [46] | ||
Src family kinases | Gastric cancer | Higashi et al. [49] | ||
human kinase PAR1b/MARK2 | Gastric cancer | Nesić et al. [45] | ||
2 | CagE type IV secretion system | Dendritic cells | MALT and Gastric cancer | Donald et al. [50] |
NF- B activator. TAK1, TRAF6, and MyD88 |
Intestinal metaplasia and Gastric cancer | Hirata et al. [51] | ||
3 | Holliday junctions resolves | Mus81 | block DNA replication | Chen et al. [52] |
4 | Mechanosensitive ion channel protein | integrin-b-catenin | human articular chondrocyte (HAC) responses | Lee et al. [53] |
Focal Adhesion Kinase pp125FAK | osteoblast activation | Rezzonico et al. [54] | ||
5 | Type IV secretion system | protein kinase B, PKB | Gastric cancer | King et al. [55] |
6 | GTPase | Guanine Nucleotide Exchange FactorSec7 Domain |
IL-8 expression | Mossessova et al. [56] |
7 | Transpoase | RNA-proteins | To regulate the RNA-proteins network | Kelley et al. [57] |
8 | VacA | VIP54 | Infection/Gastric cancer | de Bernard et al. [44] |